As trading unfolds, Stryker Corp (Symbol: SYK) has surged past the average analyst 12-month target price of $354.20, reaching $355.85 per share. When a stock hits this milestone, analysts face a crucial juncture: do they downgrade based on valuation or raise the target price in response to amplified stock performance? Their reaction hinges not just on numbers but on the fundamental business progress driving the stock up – if prospects are rosy, might it be time to elevate that target?

A total of 20 analysts within the Zacks coverage domain play a part in formulating this price average for Stryker Corp. Yet, the average is just part of the equation — individual analysts hold varying targets. Some set lower goals, with one eyeing $297.00. On the flip side, a lone analyst sets a lofty target at $400.00, showcasing a standard deviation of $22.712.

The significance of scrutinizing the average SYK price target resides in tapping into a collective “wisdom of crowds” endeavor, amalgamating insights from myriad minds, as opposed to the perspective of just one expert. With SYK surpassing the $354.20/share average target, investors in SYK receive a compelling prompt to reevaluate the company. They must weigh if $354.20 is merely a stepping stone towards a loftier target or if the valuation has stretched to a point where it’s wise to consider trimming their holdings.

The average rating in the last row of the table ranges from 1 to 5, where 1 indicates a Strong Buy and 5 reflects a Strong Sell. This data stems from Zacks Investment Research via Quandl.com. Stay updated with the latest Zacks research report on SYK — FREE.

Explore 10 ETFs With Most Upside To Analyst Targets »

Additional Insights:

• Check out LTH YTD Return
• Dive into Funds Holding JZC
• Know more about JKH outstanding shares history

The expressed views and opinions are solely those of the author and do not necessarily mirror those of Nasdaq, Inc.